CALCITONIN IN THE TREATMENT OF HYPERCALCAEMIC CRISIS

Abstract

Abstract The hypocalcaemic effect of synthetic porcine calcitonin in hypercalcaemic crisis has been studied in a 49‐year‐old man suffering from hypernephroma with skeletal metastases and a 10‐year‐old boy with a primary hyperparathyroidism. In both patients calcitonin induced prompt reduction of serum calcium concentration and pronounced clinical amelioration. This made possible successful removal of a parathyroid adenoma in the young boy. No undesirable side‐effects were observed during treatment with calcitonin.